VOL. LV, NO. 190
California State University, Long Beach December 6, 2005
.
     
 
 
 


Editorial Staff

Jamie Rowe
Editor in Chief

Austin Lewis
Managing Editor

JENNIFER FREHN
News Editor


STARR T. BALMER
City Editor

Lesley Nickus
Diversions Editor

Bradley Zint
Opinion Editor

Lauren Williams
Assistant Opinion Editor

Kim Oswell

Sports Editor

Brigid McGuire
Calendar Editor

TRACEY ROMAN
Photo Editor

ELYSSE JAMES
Copy Editor

DAVID WHISLER
Copy Editor

Beverly Munson
General Manager

Jennie Lessel
Assistant to the General Manager

Jovanna Rosado
Advertising Representative

Sara Watanasirisuk
Gynneth
Harper
Daisy Cisneros
Stacy Hopper

Office Assistants

Jamie Eggleston
Production Manager

Sara Watanasirisuk
Sarah Leavitt
Production Assistant

Gia Marie Trovela

Web Assistant

Lin Jay Wang

Circulation Staff

 

 

. News  
 

Birth control patch risks revisited


By Brittani Bixler

Online Forty-Niner
Contributing Writer



A Federal Drug Administration warning issued early this month against Ortho Evra is raising questions about the safety of the world’s first and only birth control patch.

“ I was going to start using the patch this weekend,” said Alison Nguyen as she sat in the waiting room of the Cal State Long Beach health center. “My mom read about the warning on the Internet and called me right away to make sure I didn’t start using it.”

Until this warning was issued Nov. 10, the patch-maker Ortho McNeil, a subsidiary of the Johnson and Johnson Company, said some risks could be associated with the patch as well as with the pill. The new label contradicts these statements and warns women using the patch will be exposed to about 60 percent more estrogen than those using typical birth control pills, an FDA press release stated. By being exposed to more hormones, users are at a higher risk for blood clots and other serious side effects, including stroke, the press release stated.

Alan Manack, the pharmacist in charge of the University Student Health Center at CSULB, said many women will continue using the patch despite the new warnings.
“Most women like the patch because it gives a different kind of freedom than the pill and fits their lifestyle,” Manack said.

The Ortho-Evra patch is particularly accommodating to a college student’s busy schedule because it only needs to be applied once a week, three weeks out of the month. The patch stays on for seven days and is 99.9 percent effective against pregnancy.

“ I love the patch,” said Christine Mesa, a junior at CSULB. “It is so much easier to use than the pill because I just put it on and don’t have to think about it every day.”

Not all users have such rave reviews and have chosen to post their opinions on Web sites such as rateitall.com. Others are taking their arguments to higher officials.

The law firm Parker & Waichman advertises itself as the leader in Ortho Evra litigation and evaluates possible cases for free on their official Web site, orthopatchlawsuit.com. The lawfirm’s Web site states reports showed the deaths of at least 17 young American women over the past two years may be related to the use of the Ortho Evra patch.

Otho Evra was publicly accused of its first fatality in April 2005 concerning a Manhattan fashion student who collapsed in a New York City subway station.

An autopsy discovered a blood clot traveled to the victim’s lung. The medical examiner concluded the clot was a side effect of the birth control patch the victim used. According to FDA records, 17 patch users between the ages of 17 and 30 have suffered blood clots, possible strokes and fatal heart attacks since August 2002.

The Associated Press reported Nov. 17 that the parents of Alycia Brown, a 14-year-old Wisconsin girl, are suing the Johnson and Johnson company for failing to warn users about the serious side effects of the patch. Brown died May 17, 2004 due to complications resulting from blood clots after using the patch for six weeks. She died just hours after returning home from school, where she was having breathing problems.

The La Crosse County medical examiner ruled the cause of death to be from blood clots in Brown’s lower pelvis and said Ortho Evra was a likely contributing factor. The La Crosse teen is the youngest known victim.

“ I had considered looking into Ortho Evra,” said CSULB student Morgan Cepparo, “but now, after hearing about all the risks involved, I don’t even think I would consider using it at all.”

Manack said women must remember, “there are risks involved with any hormone injections, not just the patch.”

“ I don’t understand why some girls have such problems with birth control pills,” said CSULB senior Lauren Sevilla, “I have been on birth control since I was 18 and have never had an issue with remembering when to take my pill. The patch is not even an option.”

While some students may wish to look for contraceptives other than Ortho Evra, many are weighing the risks and choosing to stick with the patch.

“ I’d rather risk the rare chance of getting a blood clot,” Mesa said, “than the definite chance of getting pregnant if I skip a pill.”

Students can visit the Student Heath Center and receive free information on the different birth control devices offered at CSULB, including the patch.




 


Calendar

Display Ads

Front Page

univmag

 

....
....

 

ADVERTISEMENT


.
©2005 Daily Forty-Niner. All rights reserved